Precision Biosciences Stock Market Value
| DTIL Stock | USD 6.50 0.68 9.47% |
| Symbol | Precision |
Precision BioSciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.4 | Revenue Per Share 12.872 | Quarterly Revenue Growth (0.96) | Return On Assets (0.06) | Return On Equity 0.2444 |
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Precision BioSciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Precision BioSciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Precision BioSciences.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Precision BioSciences on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Precision BioSciences or generate 0.0% return on investment in Precision BioSciences over 30 days. Precision BioSciences is related to or competes with ZyVersa Therapeutics, Sonnet Biotherapeutics, Zura Bio, Phio Pharmaceuticals, Transcode Therapeutics, and Quoin Pharmaceuticals. Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic... More
Precision BioSciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Precision BioSciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Precision BioSciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 19.17 | |||
| Value At Risk | (4.71) | |||
| Potential Upside | 5.37 |
Precision BioSciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Precision BioSciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Precision BioSciences' standard deviation. In reality, there are many statistical measures that can use Precision BioSciences historical prices to predict the future Precision BioSciences' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (0.62) | |||
| Treynor Ratio | (0.37) |
Precision BioSciences Backtested Returns
Precision BioSciences maintains Sharpe Ratio (i.e., Efficiency) of -0.22, which implies the firm had a -0.22% return per unit of risk over the last 3 months. Precision BioSciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Precision BioSciences' Risk Adjusted Performance of (0.06), variance of 9.01, and Coefficient Of Variation of (1,101) to confirm the risk estimate we provide. The company holds a Beta of 0.76, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Precision BioSciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Precision BioSciences is expected to be smaller as well. At this point, Precision BioSciences has a negative expected return of -0.63%. Please make sure to check Precision BioSciences' total risk alpha, as well as the relationship between the skewness and day median price , to decide if Precision BioSciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.18 |
Insignificant reverse predictability
Precision BioSciences has insignificant reverse predictability. Overlapping area represents the amount of predictability between Precision BioSciences time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Precision BioSciences price movement. The serial correlation of -0.18 indicates that over 18.0% of current Precision BioSciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.18 | |
| Spearman Rank Test | 0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.38 |
Precision BioSciences lagged returns against current returns
Autocorrelation, which is Precision BioSciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Precision BioSciences' stock expected returns. We can calculate the autocorrelation of Precision BioSciences returns to help us make a trade decision. For example, suppose you find that Precision BioSciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Precision BioSciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Precision BioSciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Precision BioSciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Precision BioSciences stock over time.
Current vs Lagged Prices |
| Timeline |
Precision BioSciences Lagged Returns
When evaluating Precision BioSciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Precision BioSciences stock have on its future price. Precision BioSciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Precision BioSciences autocorrelation shows the relationship between Precision BioSciences stock current value and its past values and can show if there is a momentum factor associated with investing in Precision BioSciences.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Precision BioSciences Correlation, Precision BioSciences Volatility and Precision BioSciences Alpha and Beta module to complement your research on Precision BioSciences. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Precision BioSciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.